Albireo Pharma Inc (NASDAQ:ALBO) has coverage initiated with a Buy rating and $62.00 price target

Analyst Ratings For Albireo Pharma Inc (NASDAQ:ALBO)

Story continues below

Today, HC Wainwright initiated coverage on Albireo Pharma Inc (NASDAQ:ALBO) with a Buy with a price target of $62.00.

There are 5 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Albireo Pharma Inc (NASDAQ:ALBO) is Buy with a consensus target price of $57.75 per share, a potential 115.49% upside.

Some recent analyst ratings include

  • 2/28/2019-Albireo Pharma Inc (NASDAQ:ALBO) has coverage initiated with a Buy rating and $62.00 price target
  • 1/25/2019-Albireo Pharma Inc (NASDAQ:ALBO) had its Buy rating reiterated by Wedbush with a $69.00 price target
  • 11/14/2018-Albireo Pharma Inc (NASDAQ:ALBO) had its Buy rating reiterated by Cowen
  • 11/13/2018-Albireo Pharma Inc (NASDAQ:ALBO) had its Buy rating reiterated by Needham & Company LLC with a $50.00 price target
  • 4/20/2018-Albireo Pharma Inc (NASDAQ:ALBO) has coverage initiated with a Buy rating and $50.00 price target
  • 11/15/2017-Albireo Pharma Inc (NASDAQ:ALBO) has coverage initiated with a Buy ➝ Buy rating and $92.00 price target
  • On 11/13/2018 Ronald Harold Wilfred Cooper, Insider, bought 1,026 with an average share price of $25.02 per share and the total transaction amounting to $25,670.52.
  • On 8/14/2018 Ronald Harold Wilfred Cooper, Insider, bought 788 with an average share price of $31.85 per share and the total transaction amounting to $25,097.80.
  • On 6/13/2018 Jan Mattsson, COO, sold 25,000 with an average share price of $32.26 per share and the total transaction amounting to $806,500.00.
  • On 1/30/2018 Phase4 Partners Ltd, Major Shareholder, sold 100,000 with an average share price of $34.44 per share and the total transaction amounting to $3,444,000.00.
  • On 1/25/2018 Life Sciences Maste Perceptive, Major Shareholder, bought 275,000 with an average share price of $33.00 per share and the total transaction amounting to $9,075,000.00.
  • On 12/1/2017 Plc Astrazeneca, Major Shareholder, sold 500,000 with an average share price of $21.40 per share and the total transaction amounting to $10,700,000.00.
  • On 12/20/2013 Brian Jg Pereira, Director, sold 4,734 with an average share price of $2.26 per share and the total transaction amounting to $10,698.84.

Recent Trading Activity for Albireo Pharma Inc (NASDAQ:ALBO)
Shares of Albireo Pharma Inc closed the previous trading session at 26,80 +0,030 0,11 % with 27.64 shares trading hands.

An ad to help with our costs